Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Details)

v3.19.2
Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 30, 2019
Jun. 24, 2018
Jun. 30, 2019
Jun. 24, 2018
Sep. 30, 2018
Segment Reporting Information [Line Items]          
Segment reporting, factors used to identify entity's reportable segments     We are organized on the basis of products and services and have three reportable segments.    
Revenues $ 9,635 $ 5,577 $ 19,459 $ 16,833  
EBT 5,501 934 6,867 1,193  
Total assets 34,133   34,133   $ 32,718
Cost of revenues (2,114) (2,491) (6,481) (7,394)  
Research and development expense (1,380) (1,416) (3,957) (4,237)  
Selling, general and administrative expense (547) (655) (1,646) (2,297)  
Other expenses (277) (112) (408) (1,605)  
Interest expense (160) (212) (477) (561)  
Investment and other income, net 344 243 377 454  
Reconciling Items [Member]          
Segment Reporting Information [Line Items]          
Revenues 4,758 27 4,855 188  
EBT 3,787 (693) 2,724 (3,712)  
Total assets 28,287   28,287   26,926
Cost of revenues (103) (135) (321) (362)  
Research and development expense (307) (293) (645) (844)  
Selling, general and administrative expense (139) (60) (285) (480)  
Other expenses (277) (112) (408) (1,605)  
Interest expense (158) (208) (471) (556)  
Investment and other income, net 58 255 188 461  
Reconciling Items [Member] | Cost of revenues [Member]          
Segment Reporting Information [Line Items]          
Unallocated acquisition-related expenses 96 127 298 335  
Reconciling Items [Member] | Research and development expenses [Member]          
Segment Reporting Information [Line Items]          
Unallocated acquisition-related expenses 1 2 3 5  
Reconciling Items [Member] | Selling, general and administrative expenses [Member]          
Segment Reporting Information [Line Items]          
Unallocated acquisition-related expenses 9 20 $ 22 310  
Corporate, Non-Segment [Member] | Reconciling Items [Member]          
Segment Reporting Information [Line Items]          
Segment reporting, change in measurement methods     In fiscal 2018, all of the costs related to pre-commercial research and development of 5G technologies, of which we recorded $124 million and $340 million in the third quarter and first nine months of fiscal 2018, respectively, were included in unallocated corporate research and development expenses. Beginning in the first quarter of fiscal 2019, all research and development costs associated with 5G technologies are included in segment results.    
Change of Segment Methodology [Member] | Reconciling Items [Member]          
Segment Reporting Information [Line Items]          
Research and development expense   124   340  
QCT [Member]          
Segment Reporting Information [Line Items]          
Segment reporting, change in measurement methods     During the first quarter of fiscal 2019, we combined our Small Cells business, which sells products designed for the implementation of small cells to address the challenge of meeting the increased demand for mobile data, into our QCT segment. Revenues and operating results related to the Small Cells business were included in nonreportable segments through the end of fiscal 2018. Prior period segment information has not been adjusted to conform to the new segment presentation as such adjustments are insignificant.    
Revenues 3,567 4,087 $ 11,028 12,635  
EBT 504 607 1,644 2,170  
Total assets 2,608   $ 2,608   3,041
QTL [Member]          
Segment Reporting Information [Line Items]          
Segment reporting, change in measurement methods     Additionally, beginning in the first quarter of fiscal 2019, certain research and development costs associated with early research and development that were historically included in our QCT segment are allocated to our QTL segment. The net effect of these changes negatively impacted QTL’s EBT by $127 million and $368 million in the third quarter and first nine months of fiscal 2019, respectively. QCT’s EBT was positively impacted by $53 million and $97 million in the third quarter and first nine months of fiscal 2019, respectively.    
Revenues 1,292 1,443 $ 3,433 3,930  
EBT 898 1,027 2,162 2,691  
Total assets 1,535   1,535   1,472
QSI [Member]          
Segment Reporting Information [Line Items]          
Revenues 18 20 143 80  
EBT 312 (7) 337 44  
Total assets 1,703   1,703   $ 1,279
Other Segments [Member]          
Segment Reporting Information [Line Items]          
Revenues 35 77 132 238  
EBT (10) (90) (57) (276)  
Impact to QTL Segment EBT due to Segment Methodology Change [Member]          
Segment Reporting Information [Line Items]          
EBT (127)   (368)    
Impact to QCT Segment EBT due to Segment Methodology Change [Member]          
Segment Reporting Information [Line Items]          
EBT 53   97    
Licensing Agreements [Member] | Reconciling Items [Member]          
Segment Reporting Information [Line Items]          
Revenues $ 4,723   $ 4,723    
Business arrangement that resolved a legal dispute [Member] | Reconciling Items [Member]          
Segment Reporting Information [Line Items]          
Revenues   $ (50)   $ (50)